Download free PDF

Pharmaceutical Plastic Packaging Market Size & Share 2025 – 2034

Market Size by Material, by Product Type, by Packaging Type, by Application and Forecast.

Report ID: GMI12844
   |
Published Date: December 2024
 | 
Report Format: PDF

Download Free PDF

Pharmaceutical Plastic Packaging Market Size

The pharmaceutical plastic packaging market was valued at USD 56.9 billion in 2024 and is estimated to grow at a CAGR of 6.5% from 2025 to 2034.

Pharmaceutical Plastic Packaging Market Key Takeaways

Market Size & Growth

  • 2024 Market Size: USD 56.9 Billion
  • 2034 Forecast Market Size: USD 106.2 Billion
  • CAGR (2025–2034): 6.5%

Key Market Drivers

  • Rising prevalence of chronic diseases and aging population.
  • Growing adoption of child-resistant and tamper-evident packaging.
  • Growth of telemedicine fueling need for secure home-delivery packaging.
  • Rising use of unit dose and multi-dose packaging formats.
  • Rapid expansion of biologics necessitating specialized packaging.

Challenges

  • Balancing cost-efficiency with high-performance packaging solutions.
  • Challenges in recycling multi-layer and specialized plastic packaging.

The pharmaceutical plastic packaging industry is witnessing a transformative shift, driven by advancements in safety, usability, and compliance with regulatory standards. Among these developments, the growing adoption of child-resistant and tamper-evident packaging is playing a pivotal role. With increasing awareness of consumer safety and the need to prevent unauthorized access, manufacturers are incorporating innovative features like breakable caps, tamper seals, and visual indicators. These solutions not only ensure product integrity but also enhance trust among consumers, particularly for prescription and over-the-counter medications. As safety remains a top priority, this trend is reshaping packaging strategies across the industry, balancing functionality with stringent safety requirements.
 

In February 2023, Berry Global Healthcare launched a new line of fully accredited child-resistant PET bottle combinations specifically designed for the pharmaceutical syrup market. This innovative packaging solution aims to address the growing demand for child-resistant (CRC) and tamper-evident (TE) features in pharmaceutical and herbal products.

 

Pharmaceutical Plastic Packaging Market

Pharmaceutical Plastic Packaging Market Trends

The pharmaceutical plastic packaging industry is undergoing significant transformation, driven by the rising integration of smart technologies into packaging solutions. With the increasing focus on patient adherence and medication tracking, smart packaging equipped with features like RFID tags, NFC technology, and QR codes is gaining traction. These innovations enable real-time monitoring of medication usage, provide reminders to patients, and ensure seamless communication between users and healthcare providers. Additionally, such technology enhances supply chain transparency, allowing stakeholders to track products and verify their authenticity. As digital health continues to evolve, the adoption of smart pharmaceutical packaging is poised to redefine patient care and operational efficiency in the industry.
 

Pharmaceutical Plastic Packaging Market Analysis

The pharmaceutical plastic packaging industry presents a significant opportunity with the increasing demand for sustainable and specialized solutions tailored to biologics and advanced therapeutics. These high-value drugs, often sensitive to environmental factors like temperature and light, require packaging that not only preserves their efficacy but also meets stringent regulatory standards. This has spurred innovation in biodegradable plastics, flexible materials, and smart packaging technologies that enhance drug stability, track usage, and improve patient compliance. Furthermore, the rise of personalized medicine has created a need for custom packaging solutions designed for smaller, patient-specific doses. However, a significant challenge remains in balancing cost-efficiency with high-performance packaging solutions. Manufacturers must navigate the complexities of delivering innovative designs and premium materials while keeping costs competitive in a market where affordability is critical to accessibility.
 

Pharmaceutical Plastic Packaging Market, By Material, 2021 - 2034 (USD Billion)

Based on material, the market is segmented into polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), polyvinyl chloride (PVC), and others. The polyethylene (PE) segment is dominating the market with a market share of over 34.5% in 2024.
 

  • Polyethylene (PE) is a key segment in the pharmaceutical plastic packaging market, driven by its versatility, durability, and cost-effectiveness. Widely used for manufacturing bottles, containers, and flexible packaging solutions, polyethylene ensures the safe storage and transportation of pharmaceutical products. Its high resistance to moisture and chemicals makes it ideal for safeguarding sensitive medications.
     
  • The increasing demand for lightweight and recyclable packaging materials has propelled the use of polyethylene in this sector, aligning with sustainability goals and regulatory requirements. The material's adaptability to various forms and sizes further strengthens its position in the market.
     
Pharmaceutical Plastic Packaging Market Share, By Packaging Type, 2024

Based on packaging type, the market is divided into flexible packaging and rigid packaging. The flexible packaging segment is projected to grow at a CAGR of over 7.5% and is expected to reach over USD 50 billion by 2034.

  • Flexible packaging is a rapidly growing segment in the pharmaceutical plastic packaging industry, offering significant advantages in terms of convenience, cost efficiency, and sustainability. This segment includes pouches, sachets, blister packs, and strip packs, which are widely used for packaging tablets, capsules, powders, and liquids. Flexible packaging provides excellent barrier properties against moisture, oxygen, and light, ensuring the integrity and shelf life of pharmaceutical products.
     
  • Its lightweight nature reduces transportation costs and environmental impact, while its adaptability to diverse designs enhances patient convenience. As the demand for portable and easy-to-use packaging solutions continues to rise, the flexible packaging segment is poised for sustained growth in the pharmaceutical sector.
     
U.S. Pharmaceutical Plastic Packaging Market Size, 2021-2034 (USD Billion)

North America dominated the market with a share of over 30% in 2024. The pharmaceutical plastic packaging market in the United States is witnessing significant advancements, driven by a growing emphasis on sustainability and smart technology integration. Manufacturers are focusing on using eco-friendly materials, such as recycled plastics and biodegradable options, while also incorporating digital features like QR codes and RFID tags to ensure product authenticity, traceability, and enhanced patient engagement. 
 

In India, the pharmaceutical plastic packaging market is rapidly expanding due to the country's booming pharmaceutical and biotechnology sectors. Manufacturers are focusing on affordability, adopting cost-effective production methods, and exploring sustainable options like recyclable and reusable plastic materials to meet the growing demand both domestically and internationally.
 

China is leading the way in the adoption of innovative pharmaceutical plastic packaging solutions, thanks to its robust manufacturing capabilities and strong government support for sustainability. The country is investing heavily in biodegradable materials and smart packaging technologies to align with global environmental and quality standards, aiming to cater to international markets with innovative, sustainable packaging solutions.
 

Japan's market is characterized by high precision and quality, particularly driven by the demand for advanced healthcare products. Japanese manufacturers are utilizing state-of-the-art molding techniques to achieve superior accuracy in packaging and are incorporating tamper-evident features to enhance safety and product integrity.
 

South Korea is seeing substantial growth in pharmaceutical plastic packaging, fueled by a government-led focus on sustainability and recycling. South Korean companies are incorporating environmentally friendly materials and focusing on supply chain efficiency, while also integrating smart packaging features to improve logistics and real-time product tracking, enhancing overall operational effectiveness.
 

Germany is at the forefront of sustainable pharmaceutical plastic packaging, with manufacturers investing in recyclable and biodegradable materials. The country's commitment to innovation ensures that its pharmaceutical packaging solutions not only meet high environmental standards but also provide superior product protection through advanced barrier technologies, making Germany a leader in the field.
 

Pharmaceutical Plastic Packaging Market Share

 Pharmaceutical Plastic Packaging Market Share Analysis, 2024

The pharmaceutical plastic packaging industry is highly competitive, with companies adopting a range of strategies to secure their position. Innovation in materials remains a key focus, with manufacturers developing packaging solutions that offer both environmental benefits and the necessary durability and sterility for pharmaceutical applications. Striking a balance between sustainability and cost-effectiveness is crucial, as companies work to introduce recyclable and biodegradable plastics that appeal to environmentally conscious consumers without increasing production costs.
 

Enhancing operational efficiency is another priority, as businesses improve supply chain resilience to manage fluctuations in demand and raw material availability. The growing emphasis on sustainability is driving the market towards circularity, with increasing investments in reusable packaging and bio-based materials that align with environmental regulations and the rising demand for green packaging solutions. To remain competitive in this dynamic market, companies must foster innovation, embrace agility, and collaborate across the value chain to provide high-quality, sustainable packaging that meets the evolving needs of both the industry and consumers.
 

Pharmaceutical Plastic Packaging Market Companies

Major players operating in the pharmaceutical plastic packaging industry are:

  • Amcor
  • APG Pharma
  • Aptar
  • Berry Global
  • Bormioli
  • CL Smith
  • Comar
  • Constantia
  • Drug Plastics
  • DWK
  • Frapak
  • Gerresheimer
  • Klockner
  • Medicopack
  • Nelipak
  • Origin Pharma
  • Plascene
  • Silgan
     

Pharmaceutical Plastic Packaging Industry News

  • In January 2024, Savillex recently launched its new Purillex PETG Square Media Bottles, specifically designed for critical applications in the life sciences sector. These bottles are manufactured from heavy-duty PETG, offering durability, shatter-resistance, and temperature-resistance, making them ideal for sensitive pharmaceutical and biotechnology applications. Available in both sterile and non-sterile formats, the bottles come in four sizes ranging from 125 mL to 1000 mL.
     
  • In January 2024, TekniPlex Healthcare, in partnership with Alpek Polyester, launched the pharmaceutical-grade polyethylene terephthalate (PET) blister film containing post-consumer recycled content. This innovative film, which will be highlighted at Pharmapack Paris, includes 30% of its material sourced from post-consumer recycled (PCR) monomers.
     

This pharmaceutical plastic packaging market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Billion) and volume (Kilo tons) from 2021 to 2034, for the following segments:

Market, By Material

  • Polyethylene (PE)
  • Polypropylene (PP)
  • Polyethylene terephthalate (PET)
  • Polyvinyl chloride (PVC)
  • Others

Market, By Product Type

  • Bottles
  • Blister packs
  • Syringes and vials
  • Films and wraps
  • Tubes
  • Pouches and sachets
  • Others

Market, By Packaging Type

  • Flexible packaging
  • Rigid packaging

Market, By Application

  • Oral drugs
  • Injectable drugs
  • Topical drugs
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia 
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • UAE
    • Saudi Arabia
    • South Africa

 

Authors:  Suraj Gujar, Sandeep Ugale

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
How big is the pharmaceutical plastic packaging market?
The market size for pharmaceutical plastic packaging was valued at USD 56.9 billion in 2024 and is projected to reach USD 106.2 billion by 2034, driven by a CAGR of 6.5% during the forecast period.
What is the market share of polyethylene (PE) in the pharmaceutical plastic packaging industry?
Polyethylene (PE) accounted for over 34.5% of the market share in 2024, driven by its versatility, durability, and cost-effectiveness in pharmaceutical packaging applications.
How much is the North America pharmaceutical plastic packaging market worth?
North America held over 30% of the market share in 2024, driven by advancements in sustainability and the integration of smart technologies in packaging solutions.
Who are the major players in the pharmaceutical plastic packaging industry?
Major players in the market include Amcor, APG Pharma, Aptar, Berry Global, Bormioli, CL Smith, Comar, Constantia, Drug Plastics, DWK, Frapak, Gerresheimer, Klockner, Medicopack, Nelipak, Origin Pharma, Plascene, and Silgan.
Pharmaceutical Plastic Packaging Market Scope
  • Pharmaceutical Plastic Packaging Market Size

  • Pharmaceutical Plastic Packaging Market Trends

  • Pharmaceutical Plastic Packaging Market Analysis

  • Pharmaceutical Plastic Packaging Market Share

Authors:  Suraj Gujar, Sandeep Ugale
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2024

Companies Profiled: 18

Tables & Figures: 596

Countries Covered: 18

Pages: 210

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)